BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35764996)

  • 1. Transthoracic, thoracoabdominal, and transabdominal surgical approaches for gastric cardia adenocarcinomas: a survival evaluation based on a cohort of 7103 patients.
    Chen Y; Zhao XK; Xu RH; Song X; Yang MM; Zhou FY; Lei LL; Fan ZM; Han XN; Gao SG; Wang XZ; Liu ZC; Li Li A; Gao WJ; Hu JF; Zhang LG; Wei JC; Jiao FL; Zhong K; Wang WP; Li LY; Ji JJ; Li XM; Wang LD
    World J Surg Oncol; 2022 Jun; 20(1):217. PubMed ID: 35764996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features of Siewert type II adenocarcinoma: comparison of gastric cardia adenocarcinoma and Barrett's esophageal adenocarcinoma following endoscopic submucosal dissection.
    Osumi H; Fujisaki J; Omae M; Shimizu T; Yoshio T; Ishiyama A; Hirasawa T; Tsuchida T; Yamamoto Y; Kawachi H; Yamamoto N; Igarashi M
    Gastric Cancer; 2017 Jul; 20(4):663-670. PubMed ID: 27783167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
    BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia.
    Kurokawa Y; Sasako M; Sano T; Yoshikawa T; Iwasaki Y; Nashimoto A; Ito S; Kurita A; Mizusawa J; Nakamura K;
    Br J Surg; 2015 Mar; 102(4):341-8. PubMed ID: 25605628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of transthoracic and transabdominal surgical approaches for the treatment of adenocarcinoma of the cardia.
    Zheng B; Chen YB; Hu Y; Wang JY; Zhou ZW; Fu JH
    Chin J Cancer; 2010 Aug; 29(8):747-51. PubMed ID: 20663322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival influence of gender on 42,345 patients with gastric cardia adenocarcinoma.
    Xu RH; Zhao XK; Song X; Lei LL; Zhong K; Han WL; Wang R; De Bao Q; Hu JF; Wei MX; Ji JJ; Li LY; Fan ZM; Han XN; Li B; Yang YZ; Sun L; Li J; Yang MM; Li XS; You D; Bai HL; Qiao JX; Xie YZ; Zhou FY; Li XM; Li AL; Wang LD
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5205-5217. PubMed ID: 36376616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of E-cadherin expression in normal mucosa, dysplasia and adenocarcinoma of gastric cardia and its influence on prognosis.
    Wang HL; Zhao XK; Zhou FY; Song X; Li LY; Huang GR; Bao QD; Lei LL; Yang HJ; Li L; Xu RH; Li AL; Wang XZ; Han WL; Ren JL; Wang LD
    World J Gastrointest Oncol; 2022 Jan; 14(1):265-277. PubMed ID: 35116116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the oesophagogastric junction Siewert II: An oesophageal cancer better cured with total gastrectomy.
    Voron T; Gronnier C; Pasquer A; Thereaux J; Gagniere J; Lebreton G; Meunier B; Collet D; Piessen G; Paye F;
    Eur J Surg Oncol; 2019 Dec; 45(12):2473-2481. PubMed ID: 31350076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
    Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
    Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of Clinical Outcomes and Prognoses in Patients With Gastroesophageal Junction Adenocarcinoma, by Transthoracic and Transabdominal Hiatal Approaches: A Teaching Hospital Retrospective Cohort Study.
    Zhou J; Wang H; Niu Z; Chen D; Wang D; Lv L; Li Y; Zhang J; Cao S; Shen Y; Zhou Y
    Medicine (Baltimore); 2015 Dec; 94(50):e2277. PubMed ID: 26683954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.
    Wang LD; Zheng S; Zheng ZY; Casson AG
    World J Gastroenterol; 2003 Jun; 9(6):1156-64. PubMed ID: 12800215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features and prognosis of gastric cardia adenocarcinoma: a multi-institutional US study.
    Amini N; Spolverato G; Kim Y; Squires MH; Poultsides GA; Fields R; Schmidt C; Weber SM; Votanopoulos K; Maithel SK; Pawlik TM
    J Surg Oncol; 2015 Mar; 111(3):285-92. PubMed ID: 25308915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer?
    Gertler R; Stein HJ; Loos M; Langer R; Friess H; Feith M
    Am J Surg Pathol; 2011 Oct; 35(10):1512-22. PubMed ID: 21934477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transhiatal versus transthoracic surgical approach for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction: a meta-analysis.
    Wu H; Shang L; Du F; Fu M; Liu J; Fang Z; Li L
    Expert Rev Gastroenterol Hepatol; 2020 Nov; 14(11):1107-1117. PubMed ID: 32757864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Neoadjuvant Chemoradiation in Patients with Gastro-esophageal Junction Adenocarcinoma: a Retrospective Cohort Study in Iran.
    Farhan F; Ghalehtaki R; Mahdavi-Seresht S; Meysamie A; Yamrali M; Farazmand B; Mohammadi N; Saraee E; Mir MR; Mir A; Lashkari M; Salarvand S; Esmati E; Samiei F
    J Gastrointest Cancer; 2019 Dec; 50(4):907-912. PubMed ID: 30402826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern diagnostics and stage-oriented surgery: therapy of adenocarcinoma of the esophagogastric junction].
    Hölscher AH; Fetzner UK
    Chirurg; 2012 Aug; 83(8):702-8, 710-1. PubMed ID: 22878576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.